ライフサイエンスコーパス: lobectomy

1 al approach (lesion excision with margins or lobectomy).

2 ed as a bridge to resection (i.e., radiation lobectomy).

3 ates ranged from 10% (prostatectomy) to 56% (lobectomy).

4 vival advantage for total thyroidectomy over lobectomy.

5 [95% CI, 1.29-1.75]; P < .001) compared with lobectomy.

6 larify the use of ECoG in tailoring temporal lobectomy.

7 val rates that approximate those achieved by lobectomy.

8 ative measurements in patients who underwent lobectomy.

9 thoracoscopic surgery (VATS) for right upper lobectomy.

10 of retinal ganglion cells follows occipital lobectomy.

11 btained by either fiberoptic bronchoscopy or lobectomy.

12 age I NSCLC patients ineligible for anatomic lobectomy.

13 ot significantly different from those having lobectomy.

14 rate and should be considered for diagnostic lobectomy.

15 donors underwent MRC, and subsequently right lobectomy.

16 ve pulmonary function in patients undergoing lobectomy.

17 survival for PTC > or =1.0 cm compared with lobectomy.

18 f 97 patients underwent diagnostic biopsy at lobectomy.

19 NSCLC were prospectively registered for VATS lobectomy.

20 al thyroidectomy, and 8946 (17.1%) underwent lobectomy.

21 long-term seizure outcome following frontal lobectomy.

22 had comorbid medical problems that precluded lobectomy.

23 raft surgery with cardiopulmonary bypass and lobectomy.

24 PVE subsequently underwent extended hepatic lobectomy.

25 intraoperative frozen section during thyroid lobectomy.

26 ts required an hepatic lobectomy or extended lobectomy.

27 olization therapy, and one patient underwent lobectomy.

28 d dysphasia for 6 months after left temporal lobectomy.

29 e free for 1 year or more following temporal lobectomy.

30 c-assisted compared with video-assisted lung lobectomy.

31 in the management of patients for radiation lobectomy.

32 Robotic-assisted or video-assisted lung lobectomy.

33 ed interest in sublobar resection in lieu of lobectomy.

34 ative measurements in patients who underwent lobectomy.

35 r long-term survival when compared with open lobectomy.

36 ients requiring a completion treatment after lobectomy.

37 | n = 3| n = 7) underwent anatomic pulmonary lobectomy.

38 and long-term survival when compared to open lobectomy.

39 ve pulmonary function in patients undergoing lobectomy.

40 y-three percent underwent minimally invasive lobectomy.

41 n = 37) and after (n = 24) anterior temporal lobectomy.

42 tients treated with limited resection versus lobectomy.

43 1.19; upper 95% CI, 1.36) were equivalent to lobectomy.

44 131)I in patients with evidence of DTC after lobectomy.

45 iated with total thyroidectomy compared with lobectomy.

46 4,926 underwent total thyroidectomy and 6849 lobectomy.

47 23), adenomata (47), and 20 live donor right lobectomies.

48 these 111 patients underwent successful VATS lobectomies.

49 obotic-assisted compared with video-assisted lobectomies.

50 12,228 prostatectomies, and 10,151 pulmonary lobectomies.

51 tended right hepatectomy (0.9%), and caudate lobectomy (0.9%).

52 ent resection, 23 (74.2%) patients underwent lobectomy, 1 (3.2%) underwent pneumonectomy, 5 (16.1%) u

53 9-1.551; P < .001) or wedge resection (HR vs lobectomy, 1.282; 95% CI, 1.179-1.394; P < .001), larger

54 1.037-1.073; P < .001), segmentectomy (HR vs lobectomy, 1.352; 95% CI, 1.179-1.551; P < .001) or wedg

55 Median follow-up of 1559 lobectomies (1204 open and 355 VATS) was 43.2 months.

56 iod: mastectomy for cancer (+19.4%), thyroid lobectomy (+14.7%), minimally invasive ventral hernia re

57 rs, and treatment distribution was 79.3% for lobectomy, 16.5% for sublobar resection, and 4.2% for SA

58 3 years, unadjusted mortality was lowest for lobectomy (25.0%), followed by sublobar resection (35.3%

59 Unadjusted 90-day mortality was highest for lobectomy (4.0%) followed by sublobar resection (3.7%; P

60 The median follow-up of 7114 lobectomies (5566 open and 1548 VATS) was 52.0 months.

61 urgery consisted of wedge resection (12.5%), lobectomy (67.8%), or pneumonectomy (19.7%).

62 minimally invasive approach (3986 [41.4%]), lobectomy (6843 [71.1%]) or segmentectomy (532 [5.5%]),

63 corrected PFTs were more likely to recommend lobectomy (79.2%; 95% CI, 69.8%-88.5%) compared with sur

64 31 laser), and 3195 underwent surgery (2350 lobectomy, 833 total thyroidectomy, 12 unspecified).

65 the equivalency of limited resection versus lobectomy according to histology is unknown.

66 the discarded terms "right and left hepatic lobectomy" after the Nomenclature was introduced in 2000

67 by completion thyroidectomy (7 [4.0%]), and lobectomy alone (8 [4.5%]).

68 Thyroid lobectomy alone may be appropriate for patients with sma

69 Among patients who underwent lobectomy alone with postoperative calcitonin levels, 5

70 acoscopic pulmonary resections, including 35 lobectomies and 15 segmentectomies, and 183 patients und

71 Sixty-four patients underwent thyroid lobectomy and 10 patients had isthmusectomy.

72 teen of these 28 patients underwent temporal lobectomy and 13 were not offered surgery.

73 ergoing pre-surgical evaluation for temporal lobectomy and 30 normal subjects performed a complex vis

74 From 3339 lobectomy and 355 pneumonectomy patients identified, we

75 e on preoperative ultrasonography, a thyroid lobectomy and central neck dissection may be considered.

76 mpal specimens were obtained during temporal lobectomy and frozen quickly.

77 Non-cardiac related procedures, lung lobectomy and hip replacement (partial and total) were i

78 e of the study was to compare survival after lobectomy and limited resection among Medicare patients

79 aluation in less than 24 hr, and donor right lobectomy and living donor transplantation were performe

80 nderwent video-assisted thoracoscopic (VATS) lobectomy and measurement of post-operative FEV1 and DLC

81 ients underwent video-assisted thoracoscopic lobectomy and measurement of postoperative FEV1 and DLCO

82 He then undergoes right upper lobectomy and mediastinal lymph node dissection, which d

83 n between activation ipsilateral to temporal lobectomy and memory outcome was observed, with no signi

84 Single-incision thoracoscopic lobectomy and segmentectomy are feasible, and perioperat

85 Reports of single-incision thoracoscopic lobectomy and segmentectomy for lung cancer are limited,

86 Single-incision thoracoscopic lobectomy and segmentectomy were associated with shorter

87 incision and multiple-incision thoracoscopic lobectomy and segmentectomy.

88 demonstrated the best outcomes compared with lobectomy and with no therapy for nonsolid nodules.

89 ections included 237 trisegmentectomies, 394 lobectomies, and 370 resections encompassing less than a

90 horacic cavity (mediastinal mass resections, lobectomies, and esophagectomies); unfortunately there a

91 nt pneumonectomy, 5 (16.1%) underwent sleeve lobectomy, and 2 (6.5%) with bilobectomy.

92 grafting, lower-extremity bypass, colectomy, lobectomy, and nephrectomy.

93 gent chemotherapy, resection with at least a lobectomy, and PORT (hazard ratio, 0.886; 95% CI, 0.798

94 gent chemotherapy, resection with at least a lobectomy, and PORT.

95 caused by temporopolar strokes and temporal lobectomy are far less severe than those seen in temporo

96 s on long-term survival for VATS versus open lobectomy are limited.

97 herapy with or without resection (preferably lobectomy) are options for patients with stage IIIA(N2)

98 ctive randomized clinical trials to evaluate lobectomy as a biochemical cure in patients presenting w

99 A standardized approach to VATS lobectomy as specifically defined with avoidance of rib

100 Anterior temporal lobectomy (ATL) remains an option for patients with MRgL

101 rwent either a craniotomy, Anterior Temporal Lobectomy (ATL), or a less invasive method of Selective

102 e recall) underwent either anterior temporal lobectomy (ATL: n=38) or stereotactic laser amygdalohipp

103 es should explore the potential for temporal lobectomy based on interictal electroencephalography and

104 consecutively treated with anterior temporal lobectomy between 1986 and 1990.

105 reviewed 70 patients who underwent a frontal lobectomy between 1995 and 2003 (mean follow-up 4.1 +/-

106 ecutive patients who underwent thoracoscopic lobectomy between June 1999 and January 2006 was queried

107 e advantageous in patients planned for right lobectomies but further research is warranted.

108 e advantageous in patients planned for right lobectomy, but further research is warranted.

109 ation and oxidative stress in patients after lobectomy, but not after the milder insult associated wi

110 , OS was improved for patients who underwent lobectomy, but not pneumonectomy, versus chemotherapy pl

111 l cell lung cancer (NSCLC), as compared with lobectomy by conventional thoracotomy, include less post

112 se was queried for patients having undergone lobectomy by either thoracotomy or VATS between 2000 and

113 2.31; 95% CI, 10 063.66-15 420.94; P < .001; lobectomy: coefficient, 6336.42; 95% CI, 3934.61-8737.24

114 s used to identify matched segmentectomy and lobectomy cohorts (n = 312 patients per group) using a p

115 e-matching analysis of well-matched SABR and lobectomy cohorts demonstrated similar overall survival

116 Left lobectomy, conceived to supply more tissue, still provid

117 d bile duct and liver resection with caudate lobectomy contributed to a higher margin-negative resect

118 Right lobectomy could supply a graft of adequate size.

119 isk DTC requiring completion treatment after lobectomy due to specific individual risk factors or pat

120 g coronary artery bypass grafting, pulmonary lobectomy, endovascular abdominal aortic aneurysm repair

121 t coronary artery bypass grafting, pulmonary lobectomy, endovascular abdominal aortic aneurysm repair

122 r coronary-artery bypass grafting, pulmonary lobectomy, endovascular repair of abdominal aortic aneur

123 Compared to lobectomy, excess mortality after pneumonectomy extends

124 ncluded 13 right trisegmentectomies, 6 right lobectomies extended to include the caudate lobe, and 3

125 sisted of total thyroidectomy (161 [91.0%]), lobectomy followed by completion thyroidectomy (7 [4.0%]

126 metastatic NSCLC who had received at least a lobectomy followed by multiagent chemotherapy and radiot

127 Right lobectomies for living donation can be performed safely

128 obtained lung tissue from 69 subjects having lobectomies for lung cancer.

129 s of patients who underwent open versus VATS lobectomy for clinical T1-2, N0, M0 NSCLC in the Nationa

130 in long-term survival when compared to open lobectomy for cT1-2N1M0 non-small-cell lung cancer (NSCL

131 Advantages of thoracoscopic lobectomy for early stage non-small cell lung cancer (NS

132 survival of open versus thoracoscopic (VATS) lobectomy for early stage non-small-cell lung cancer (NS

133 Hurthle cell carcinomas and reserve thyroid lobectomy for Hurthle cell adenomas.

134 tissue from patients who underwent temporal lobectomy for intractable epilepsy.

135 to be a universal event after right hepatic lobectomy for live-donor adult liver transplantation acc

136 total of 958 consecutive patients undergoing lobectomy for lung cancer at 3 centers from 2014 to 2017

137 Database was queried for patients undergoing lobectomy for lung cancer from 2004 to 2013 at Commissio

138 hospital readmission for patients undergoing lobectomy for lung cancer.

139 cohort study of patients undergoing elective lobectomy for lung cancer.

140 ons are the main driver of readmission after lobectomy for lung cancer.

141 of LOS and postoperative complications after lobectomy for lung cancer.

142 tween 2002 and 2020 from patients undergoing lobectomy for lung tumors.

143 and duration of air leakage after pulmonary lobectomy for malignancy.

144 Ms and control brains obtained from temporal lobectomy for medically intractable seizures.

145 mygdalohippocampectomy and anterior temporal lobectomy for mTLE with MTS.

146 evaluating the impact of a VATS approach to lobectomy for N1 NSCLC on short-term outcomes and surviv

147 uded (unused donor lungs, n = 4; pre-emptive lobectomy for oncologic indications, n = 2).

148 r surgical history included prior left upper lobectomy for remote left upper lobe stage IIIA adenocar

149 ty of video-assisted thoracic surgery (VATS) lobectomy for small lung cancers.

150 we identified elderly patients who underwent lobectomy for stage I NSCLC.

151 years of age undergoing limited resection or lobectomy for stage IA tumors < or =2 cm appears to be s

152 geons who recommend total thyroidectomy over lobectomy for subcentimeter unifocal thyroid cancer were

153 lective amygdalohippocampectomy and temporal lobectomy for temporal lobe epilepsy were associated wit

154 tients who had undergone unilateral temporal lobectomy for the treatment of epilepsy (12 left, 11 rig

155 ative) in 95 patients who underwent temporal lobectomy for treatment of nonneoplastic epilepsy were e

156 tients undergoing total thyroidectomy versus lobectomy for tumors 1.0-4.0 cm [hazard ratio (HR) = 0.9

157 =18 years who underwent wedge hepatectomy or lobectomy from 2000 to 2014.

158 ve (robotic-assisted or video-assisted) lung lobectomy from January 1, 2020, to December 31, 2022, wi

159 % in the segmentectomy group and 2.5% in the lobectomy group (P = .38).

160 hat routinely discharge patients early after lobectomy have increased readmissions.

161 ivalent survival rates to those treated with lobectomy (HR, 0.97; upper 95% CI, 1.07), outcomes of th

162 Cases of amnesia after unilateral temporal lobectomy illustrate the complexity of intra- and inter-

163 dited hospitals, which performed at least 25 lobectomies in a 2-year period.

164 nonlesional patients who underwent temporal lobectomies in our epilepsy center from 1995 to 1998.

165 To measure the economic impact of avoiding lobectomies in patients with benign core-needle biopsy f

166 or subtotal thyroidectomy in 47 patients and lobectomy in 55 patients.

167 t reduces the costs of diagnosis compared to lobectomy in benign nodules.

168 that limited resection is not equivalent to lobectomy in older patients with invasive non-small-cell

169 that limited resection was not equivalent to lobectomy in patients with adenocarcinoma (HR, 1.21; upp

170 The cost savings of avoiding lobectomy in patients with benign nodules and stability

171 ical data relate to prognosis after temporal lobectomy in patients with independent bilateral tempora

172 The outcomes after thoracoscopic lobectomy in patients with more complex pulmonary condit

173 associated with better overall survival than lobectomy in the first 6 months after diagnosis (AHR, 0.

174 imited resection (wedge or segmentectomy) or lobectomy in the Surveillance, Epidemiology, and End Res

175 ry, in 1 of whom there was radioembolization lobectomy intent.

176 Temporal lobectomy is an effective therapy for medically refracto

177 Thoracoscopic lobectomy is applicable to a spectrum of malignant and b

178 Hospital readmission after lobectomy is associated with increased mortality.

179 video-assisted thoracoscopic surgery (VATS) lobectomy is beneficial in high-risk pulmonary patients.

180 patient selection for robotic-assisted lung lobectomy is needed to improve resource utilization.

181 Temporal lobectomy is often complicated by superior quadrantanopi

182 Either TT or lobectomy is often needed to diagnose differentiated thy

183 Lobectomy is the standard of care for stage IA lung canc

184 tive histologic margins, concomitant hepatic lobectomy, lack of nodal disease, well-differentiated hi

185 Left temporal lobectomy (LTL) and healthy comparison groups generated

186 topographical memory, and the left temporal lobectomy (LTL) patients worse on tests of context-depen

187 patients underwent mediastinoscopy (n = 3), lobectomy (n = 2), thoracoscopic wedge resection (n = 2)

188 Patients who only underwent lobectomy (n = 6) or declined to participate (n = 5) wer

189 tion (right trisegmentectomy [n = 13], right lobectomy [n = 3]) without mortality.

190 p of 5.4 years, comparing segmentectomy with lobectomy, no differences were noted in locoregional (5.

191 rthermore, when comparing segmentectomy with lobectomy, no significant differences were noted in 5-ye

192 All were ineligible for anatomic lobectomy; of those receiving SBRT, 95% were medically i

193 (NSCLC) using a standard definition for VATS lobectomy (one 4- to 8-cm access and two 0.5-cm port inc

194 atients with stage 0-IIB NSCLC who underwent lobectomy or bilobectomy at three hospitals between 2014

195 18 years of age scheduled for elective open lobectomy or bilobectomy for malignancy were eligible fo

196 markers were associated with worse OS after lobectomy or bilobectomy of stage 0-IIB NSCLC, independe

197 Half of the patients required an hepatic lobectomy or extended lobectomy.

198 ung cancer < or =2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge r

199 r-specific survival of patients treated with lobectomy or limited resection was compared after adjust

200 ession-free survival rate was the same after lobectomy or more extensive thyroid procedures, but comp

201 n, bilateral resection, extensive resection (lobectomy or more), gender, number of hepatic tumors, pr

202 rate of 4.6% for resections that involved a lobectomy or more.

203 collapse in patients who have had a previous lobectomy or pneumonectomy and require thoracic surgery.

204 tation, n = 13) and control subjects (during lobectomy or pneumonectomy for cancer, n = 14).

205 Patients undergoing lobectomy or pneumonectomy for lung cancer at our instit

206 ) analysis in the 180 patients who underwent lobectomy or pneumonectomy led to the elimination of sex

207 Lobectomy or pneumonectomy should be performed in stage

208 Lobectomy or pneumonectomy vs sublobar resection.

209 entified patients undergoing lung resection (lobectomy or pneumonectomy) for lung cancer.

210 aging and resection of the tumor (usually by lobectomy or pneumonectomy), the patients were randomly

211 ical patients who had previous contralateral lobectomy or pneumonectomy.

212 cally confirmed T2N0 NSCLC and had undergone lobectomy or pneumonectomy.

213 ts underwent multiple-incision thoracoscopic lobectomy or segmentectomy between January 2005 and Dece

214 incision and multiple-incision thoracoscopic lobectomy or segmentectomy for lung cancer has not been

215 nts with lung cancer underwent thoracoscopic lobectomy or segmentectomy via a single-incision or mult

216 Review disclosed 583 patients who underwent lobectomy or segmentectomy.

217 limbic networks, a juxtaposition not seen in lobectomy or stroke.

218 A total of 74 patients who underwent thyroid lobectomy or thyroid isthmusectomy between 1985 and 2015

219 tomy (OR, 1.93 [95% CI, 1.34-2.77]), thyroid lobectomy (OR, 1.43 [95% CI, 1.32-1.54]), breast lumpect

220 ablation, 35% partial hepatectomy (ie, left lobectomy), or a sham operation (controls) by using Kapl

221 iting list to undergo, lung transplantation, lobectomy, or lung volume-reduction surgery, or had sele

222 titution series demonstrated benefit of VATS lobectomy over lobectomy via thoracotomy in poor pulmona

223 ons (p < 0.001), segmentectomies (p = 0.02), lobectomies (p = 0.003), and thymectomies (p = 0.02).

224 ormance was observed following left temporal lobectomy (P = 0.002).

225 significantly improved after right temporal lobectomy (P = 0.015) while a decrement in performance w

226 TT (P = 0.006) and a lower rate of sTC after lobectomy (P = 0.03).

227 otal thyroidectomy, and 89% in patients with lobectomy (p = 0.30).

228 re similar (46% for pneumonectomy vs 43% for lobectomy; P = 0.40), but rates of major complications (

229 including 392 segmentectomy patients and 800 lobectomy patients was used to identify matched segmente

230 Seventeen right and 13 left temporal lobectomy patients were compared with 16 healthy matched

231 increase at a significantly greater rate in lobectomy patients with poor pulmonary function after th

232 Compared with lobectomy, patients undergoing total thyroidectomy had m

233 tios were determined intraoperatively during lobectomies performed to alleviate drug-resistant seizur

234 ic rate of glucose (CMRglc) PET for temporal lobectomy planning.

235 ET and CMRglc PET can contribute to temporal lobectomy planning.

236 frontal eyefield ablation, or after frontal lobectomy plus forebrain commissurotomy (n = 3 in each o

237 rgoing 5 complex cancer surgeries (pulmonary lobectomy, pneumonectomy, esophagectomy, gastrectomy, an

238 truction, carotid endarterectomy (CEA), lung lobectomy/pneumonectomy, open and laparoscopic cholecyst

239 rapy and lung cancer status after left upper lobectomy presented to our hospital for elective cardiov

240 Temporal lobectomy provides sustained seizure relief over 5 years

241 At the time of lobectomy, pulmonary artery and vein were identified, an

242 For tumors > or =1 cm, lobectomy resulted in higher risk of recurrence and deat

243 leasant memories, whereas the right temporal lobectomy (RTL) group produced significantly fewer memor

244 y and test type such that the right temporal lobectomy (RTL) patients were worse on tests of topograp

245 ter the type or completeness of the surgery (lobectomy: S: 56%, CT-S: 60%, complete resection: S: 80%

246 able transcriptomic data from human temporal lobectomy samples, we confirmed a previously described p

247 Radioisotopic lobectomy should be considered for patients with low- to

248 ancer and who would require extended hepatic lobectomy should have hepatic resection delayed for at l

249 Histological results obtained from left lobectomy specimens showed hepatobiliary cystadenocarcin

250 al components of microdysgenesis in temporal lobectomy specimens.

251 underwent definitive treatment consisting of lobectomy, sublobar resection, or stereotactic ablative

252 studies involving patients who had temporal lobectomy surgeries have also revealed changes in emotio

253 essment of memory changes following temporal lobectomy surgery emphasize the complexity of subjective

254 By contrast, after lobectomy, the concentration in exhaled breath condensat

255 Following lobectomy, there appears to be a truly asymmetric form o

256 the STS database, 12,970 patients underwent lobectomy (thoracotomy, n = 8439; VATS, n = 4531) and me

257 ntribute to reducing the need for diagnostic lobectomies/thyroidectomies.

258 reated specifically for analysis of temporal lobectomy tissue and the Braak staging, which was limite

259 , n = 10; smoker+COPD, n = 17), 3) pulmonary lobectomy tissue samples (no/mild emphysema, n = 6), and

260 tial memory of 19 left and 19 right temporal lobectomy (TL) patients was compared with that of 16 nor

261 , hysterectomy, peripheral bypass, pulmonary lobectomy, total hip arthroplasty, and total knee arthro

262 Immediately after lobectomy, tumor and lung specimens were snap frozen.

263 The donor operation consisted of a right lobectomy uniformly performed throughout the series as d

264 e studied 29 patients with anterior temporal lobectomies using Goldmann perimetry.

265 demonstrated benefit of VATS lobectomy over lobectomy via thoracotomy in poor pulmonary function pat

266 Lobectomy was associated with better outcomes than sublo

267 In this large propensity-matched comparison, lobectomy was associated with modestly increased freedom

268 In this national analysis, thoracoscopic lobectomy was associated with shorter hospital stay and

269 VATS lobectomy was associated with shorter length of stay and

270 ctomy was the appropriate extent of surgery, lobectomy was correctly performed more often with routin

271 erentially impaired following right temporal lobectomy was employed.

272 nts who underwent resection, en bloc caudate lobectomy was performed in 8% of the Lahey patients and

273 Thoracoscopic lobectomy was successfully performed in 492 patients (co

274 In the 501 patients with non-sTC for whom lobectomy was the appropriate extent of surgery, lobecto

275 Lobectomy was the most common procedure (48 of 68 [70.6%

276 In this national analysis, VATS lobectomy was used in the minority of N1 NSCLC cases but

277 In this national analysis, VATS lobectomy was used in the minority of patients with stag

278 Procedures were categorized as lobectomy, wedge resection, or enucleation/ablation.

279 between video-assisted and robotic-assisted lobectomies were generated using the Wilcoxon rank sum t

280 ytic neoplasm) cytology who received initial lobectomy were 2.5 times more likely to require 2-stage

281 -small cell lung cancer patients planned for lobectomy were prospectively enrolled (68% male; average

282 ell lung cancer (NSCLC) patients planned for lobectomy were prospectively enrolled (68% males, averag

283 s with thyroid surgery (total of 414 thyroid lobectomies) were collected.

284 ood (usually as part of an anterior temporal lobectomy) were not impaired in ToM reasoning relative t

285 treated with limited resection compared with lobectomy when data was analyzed stratifying and matchin

286 ltrations - fibrotic changes, giving rise to lobectomy, while in the last of these cases, the course

287 (TLE) undergoing standard anterior temporal lobectomy with amygdalohippocampectomy (ATL), but the ut

288 Left anterior temporal lobectomy with amygdalohippocampectomy rendered the pati

289 ion in 41 patients who had anterior temporal lobectomy with at least a 1-y follow-up.

290 s treated using unilateral anterior temporal lobectomy with hippocampal resection.

291 randomly assigned in a 1:1 ratio to SABR or lobectomy with mediastinal lymph node dissection or samp

292 age I, non-small-cell lung cancer (NSCLC) is lobectomy with mediastinal lymph node dissection or samp

293 A total of 35 underwent donor right lobectomy with no significant complications.

294 ly-stage (I or II) lung cancer who underwent lobectomy with nodal dissection.

295 odes, sublobar resection was not inferior to lobectomy with respect to disease-free survival.

296 Lobectomy with systematic lymph node evaluation remains

297 and 17.8% (806/4531) in patients undergoing lobectomy with thoracotomy and VATS, respectively (P < 0

298 Survival rates are comparable to those for lobectomy with thoracotomy.

299 ingle individual underwent anterior temporal lobectomy, with subsequent seizure freedom and histopath

300 th clinical T1-2, N1, M0 NSCLC who underwent lobectomy without induction therapy in the National Canc